232SM203 DEVOTE clinical trial Escalating Dose and Randomized, Controlled Study of Nusinersen in Participants with Spinal Muscular Atrophy

Activity: ConsultancyProfessional

Description

advisory services and training evaluators regarding the Endurance Shuttle Box and Block Test (ESBBT) and motor fatigability Tests
PeriodSept 2021
Work forBiogen IDEC, United States
Degree of RecognitionInternational